HETARYL-[1,8]NAPHTHYRIDINE DERIVATIVES

Novel hetaryl-[1,8]naphthyridine derivatives of formula (I) wherein R1, R2, W1, W3, W5 and W6 have the meaning according to claim 1, are inhibitors of ATP consuming proteins, and can be employed, inter alia, for the treatment of tumors. Los derivados novedosos de hetaril-[1,8]naftiridina de la fórmu...

Full description

Saved in:
Bibliographic Details
Main Authors ALFRED JONCZYK., FRANK ZENKE, DIETER DORSCH, CHRISTIANE AMENDT, GUENTER HOELZEMANN
Format Patent
LanguageEnglish
Spanish
Published 07.09.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Novel hetaryl-[1,8]naphthyridine derivatives of formula (I) wherein R1, R2, W1, W3, W5 and W6 have the meaning according to claim 1, are inhibitors of ATP consuming proteins, and can be employed, inter alia, for the treatment of tumors. Los derivados novedosos de hetaril-[1,8]naftiridina de la fórmula (I) en donde R1, R2, W1, W3, W5 y W6 tienen el significado de acuerdo con la reivindicación 1, son inhibidores de proteínas que consumen ATP y se pueden emplear, inter alia, para el tratamiento de tumores.
Bibliography:Application Number: MX20120008550